×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Ovarian Cancer
Feature Video
Dr Shannon Westin, a clinical investigator at the MD Anderson Cancer Center, discusses PARP inhibition for patients with deleterious or suspected deleterious germline BRCA-mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.
Kelly Irvin
Researchers disagree on whether or not to monitor ovarian cancer survivors with frequent CA-125 tests. But this patient would rather have more information than less.
Patrick Dempsey
Patrick Dempsey discusses National Ovarian Cancer Awareness Month.
Tracy Posner
Life after a hysterectomy is one of the many challenges I have had to overcome.
Jessica Skarzynski
A new tool that helps surgeons distinguish healthy tissue from tumor in real-time could change the landscape of surgical ovarian cancer treatment for the better.
Katie Kosko
Researchers may have found a potential new way to treat patients with ovarian or lung cancer who had previously failed other treatments, according to early trial findings published in Annals of Oncology.
The Foundation for Women’s Cancer Continues the Fight to End Gynecologic Cancer One Step at a Time; Race Set for Nov. 4, 2018 in Washington, DC
Kristie L. Kahl
In this week’s episode, we speak with author and avid patient advocate Shannon Pulaski about her new efforts to help empower children to learn about their family’s health history.
Brielle Urciuoli
In recent years, treatment has expanded for mutations that are well-understood in this space.
Kristie L. Kahl
A recent survey of physicians revealed that 17 percent of doctors with personal experience with cancer were more likely than those without to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.